on 07 Sep 2021
Last Applicant/ Owned by
Babraham Research Campus
Cambridge
GB
CB223AT
Serial Number
88441516 filed on 22nd May 2019
Registration Number
6473731 registered on 07th Sep 2021
Correspondent Address
Mark H. Tidman
BAKER & HOSTETLER LLP
1050 Connecticut Avenue, NW
Washington Square, Suite 1100
Washington, DC 20036-5403
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Pharmaceutical and medical preparations containing monoclonal antibodies for the treatment and prophylaxis of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; Veterinary preparations containing monoclonal antibodies for treatment and prophylaxis of medical conditiRead More
Pharmaceutical and medical preparations containing monoclonal antibodies for the treatment and prophylaxis of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; Veterinary preparations containing monoclonal antibodies for treatment and prophylaxis of medical conditions in humans, namely, cancer, inflammatory, autoimmune and infectious diseases, and medical diagnostics; sanitary preparations containing monoclonal antibodies for medical purposes; dietetic food and beverages containing monoclonal antibodies, for medical and veterinary use; dietary supplements containing monoclonal antibodies for human beings and animals; dietary supplements containing monoclonal antibodies; Pharmaceutical preparations containing monoclonal antibodies for the treatment of treatment and prophylaxis of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases and in the field of antibodies and immuno-oncology
Scientific, medical and technological services, namely, scientific research, analysis and testing in the field of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology, and scientific research, analysis and testing in the field of antibodies and cell repertoires and research, development and design in the field of science, medicine, and technology; industrial analysis and industrial research services, namely, testing, analysis, and evaluation of the goods of others to assure compliance with industry standards; design and development of computer hardware and software; design and development of hardware and software for analysis and testing in the field of antibodies and biological cells and genetic discovery and clinical development; Clinical research in the field of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies, immuno-oncology, inflammation, haematology and infectious disease; Conducting clinical trials for others in the field of antibodies, and medical conditions, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; conducting clinical trials for pharmaceutical products for others in the field of medical conditions, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; scientific and medical screening and assaying of medical conditions, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; scientific and medical screening and assaying in the field of genetic discovery, clinical development, antibodies and biological cells; chemical analysis; chemical research
Medical services; diagnostic and prognostic medical services; veterinary services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; pharmaceutical consultation in the nature of pharmacy advice; medical and health services in the nature of the treatment and prophylaxis of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics; Medical screening
No 88441516
No Service Mark
No 86291.020191
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 07th Sep 2021 | REGISTERED-PRINCIPAL REGISTER |
| 01st Aug 2021 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| 21st Apr 2021 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| 23rd Mar 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 23rd Mar 2021 | PUBLISHED FOR OPPOSITION |
| 03rd Mar 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 17th Feb 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 17th Feb 2021 | EXAMINERS AMENDMENT E-MAILED |
| 17th Feb 2021 | EXAMINERS AMENDMENT -WRITTEN |
| 17th Feb 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
